Literature DB >> 23332215

Role of leptin in pregnancy: consequences of maternal obesity.

D R Tessier1, Z M Ferraro, A Gruslin.   

Abstract

Maternal obesity is associated with increased risks of pregnancy complications. Excessive fat mass, common to obese women, has the potential to influence production and secretion of adipose tissue derived proteins called adipokines. The adipokine leptin is involved in the regulation of multiple aspects of maternal metabolic homeostasis. In addition, leptin has been shown to be important for placentation and maternal-fetal exchanges processes regulating growth and development. In later stages of a healthy pregnancy, central leptin resistance occurs to allow increased nutrient availability for the fetus. Disruption of the signaling capacity of leptin associated with obesity is emerging as a potential risk factor leading to pregnancy complications as a result of aberrant fuel partitioning in utero. In this review we discuss the influence of obesity on the roles of leptin and leptin resistance at the central and placental level.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23332215     DOI: 10.1016/j.placenta.2012.11.035

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  51 in total

1.  Longitudinal changes in adipokines and free leptin index during and after pregnancy in women with obesity.

Authors:  Ulrika Andersson-Hall; Pernilla Svedin; Henrik Svensson; Malin Lönn; Carina Mallard; Agneta Holmäng
Journal:  Int J Obes (Lond)       Date:  2019-09-24       Impact factor: 5.095

2.  Maternal obesity and gestational diabetes are associated with placental leptin DNA methylation.

Authors:  Corina Lesseur; David A Armstrong; Alison G Paquette; Zhigang Li; James F Padbury; Carmen J Marsit
Journal:  Am J Obstet Gynecol       Date:  2014-06-19       Impact factor: 8.661

Review 3.  Impact of maternal obesity on fetal programming of cardiovascular disease.

Authors:  Victoria H J Roberts; Antonio E Frias; Kevin L Grove
Journal:  Physiology (Bethesda)       Date:  2015-05

Review 4.  The placenta: a multifaceted, transient organ.

Authors:  Graham J Burton; Abigail L Fowden
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-03-05       Impact factor: 6.237

5.  Standardization of amniotic fluid leptin levels and utility in maternal overweight and fetal undergrowth.

Authors:  M Scott-Finley; J G Woo; M Habli; O Ramos-Gonzales; J F Cnota; Y Wang; B D Kamath-Rayne; A C Hinton; W J Polzin; T M Crombleholme; R B Hinton
Journal:  J Perinatol       Date:  2015-04-30       Impact factor: 2.521

6.  Sex-specific associations between placental leptin promoter DNA methylation and infant neurobehavior.

Authors:  Corina Lesseur; David A Armstrong; Megan A Murphy; Allison A Appleton; Devin C Koestler; Alison G Paquette; Barry M Lester; Carmen J Marsit
Journal:  Psychoneuroendocrinology       Date:  2013-10-30       Impact factor: 4.905

7.  RNA-seq analysis of the rat placentation site reveals maternal obesity-associated changes in placental and offspring thyroid hormone signaling.

Authors:  J Saben; P Kang; Y Zhong; K M Thakali; H Gomez-Acevedo; S J Borengasser; A Andres; T M Badger; K Shankar
Journal:  Placenta       Date:  2014-10-05       Impact factor: 3.481

Review 8.  Effects of maternal obesity on placental function and fetal development.

Authors:  Kristy R Howell; Theresa L Powell
Journal:  Reproduction       Date:  2016-11-18       Impact factor: 3.906

9.  Serum leptin levels and reproductive function during the menstrual cycle.

Authors:  Katherine Ahrens; Sunni L Mumford; Karen C Schliep; Kerri A Kissell; Neil J Perkins; Jean Wactawski-Wende; Enrique F Schisterman
Journal:  Am J Obstet Gynecol       Date:  2013-11-08       Impact factor: 8.661

10.  Association Between Gestational Weight Gain and Autism Spectrum Disorder in Offspring: A Meta-Analysis.

Authors:  Le Su; Cheng Chen; Liping Lu; Anny H Xiang; Linda Dodds; Ka He
Journal:  Obesity (Silver Spring)       Date:  2020-10-01       Impact factor: 5.002

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.